ATE344659T1 - Tablettenzubereitung mit verlängerter freisetzung von venlafaxin - Google Patents

Tablettenzubereitung mit verlängerter freisetzung von venlafaxin

Info

Publication number: ATE344659T1
Authority: AT; Austria
Prior art keywords: core; venlafaxine; filler; cellulosic polymer; microcrystalline cellulose
Prior art date: 2003-05-02

Application number

AT03101216T

Other languages

English (en)

Inventor

Sima Volpert

Avi Avramoff

Original Assignee

Dexcel Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-02

Filing date

2003-05-02

Publication date

2006-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32981939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE344659(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-05-02 Application filed by Dexcel Ltd filed Critical Dexcel Ltd

2006-11-15 Application granted granted Critical

2006-11-15 Publication of ATE344659T1 publication Critical patent/ATE344659T1/de

Links

PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 title abstract 3
229960004688 venlafaxine Drugs 0.000 title abstract 3
238000013265 extended release Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 abstract 5
239000000945 filler Substances 0.000 abstract 4
238000009472 formulation Methods 0.000 abstract 4
229920000642 polymer Polymers 0.000 abstract 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 4
229920000168 Microcrystalline cellulose Polymers 0.000 abstract 3
239000011248 coating agent Substances 0.000 abstract 3
238000000576 coating method Methods 0.000 abstract 3
235000019813 microcrystalline cellulose Nutrition 0.000 abstract 3
239000008108 microcrystalline cellulose Substances 0.000 abstract 3
229940016286 microcrystalline cellulose Drugs 0.000 abstract 3
239000002552 dosage form Substances 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
239000007935 oral tablet Substances 0.000 abstract 1
229940096978 oral tablet Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT03101216T 2003-05-02 2003-05-02 Tablettenzubereitung mit verlängerter freisetzung von venlafaxin ATE344659T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03101216.4A EP1473030B2 (de)	2003-05-02	2003-05-02	Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin

Publications (1)

Publication Number	Publication Date
ATE344659T1 true ATE344659T1 (de)	2006-11-15

Family

ID=32981939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03101216T ATE344659T1 (de)	2003-05-02	2003-05-02	Tablettenzubereitung mit verlängerter freisetzung von venlafaxin

Country Status (8)

Country	Link
US (1)	US8105627B2 (de)
EP (1)	EP1473030B2 (de)
AT (1)	ATE344659T1 (de)
CA (1)	CA2524241A1 (de)
DE (1)	DE60309565T3 (de)
ES (1)	ES2277030T3 (de)
PT (1)	PT1473030E (de)
WO (1)	WO2004096186A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1473030B2 (de)	2003-05-02	2014-05-14	Dexcel Ltd.	Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin
US20080175873A1 (en) *	2005-06-02	2008-07-24	Biovail Laboratories International S.R.L.	Modified release composition of at least one form of venlafaxine
WO2006136927A1 (en) *	2005-06-22	2006-12-28	Glenmark Pharmaceuticals Limited	Extended release formulations comprising venlafaxine
GT200600307A (es) *	2005-07-15	2008-04-24		Formas de dosificacion de liberacion retardada oral altamente biodisponibles de succinato de o-desmetilvenlafaxina
WO2007112574A1 (en) *	2006-04-03	2007-10-11	Isa Odidi	Extended release composition of venlafaxine
WO2007129329A2 (en) *	2006-05-08	2007-11-15	Jubilant Organosys Limited	Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
EP2074993A1 (de) *	2007-12-19	2009-07-01	Biovail Laboratories International S.r.l.	Venlafaxin enthaltende Filmtabletten mit modifizierter Wirkstofffreisetzung
US20110052690A1 (en) *	2008-06-02	2011-03-03	Avi Avramoff	Process for manufacture of a medicament with granulation and pan coating
WO2010089775A2 (en) *	2009-02-05	2010-08-12	Getz Pharma Research	Improved drug dosage form for controlled delivery of one or more pharmaceutically active agent
CA2788526A1 (en) *	2010-05-14	2011-11-17	Alembic Limited	Extended release formulations of desvenlafaxine base
US9333175B2 (en) *	2010-06-16	2016-05-10	Mylan Inc.	Controlled release levetiracetam formulations and methods for producing the same
US20120251588A1 (en) *	2011-03-30	2012-10-04	Miyuki Fukasawa	Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
EP3788884A1 (de) *	2019-09-05	2021-03-10	Delica AG	Kompostierbare kapsel sowie deren herstellung und verwendung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4535186A (en)	1983-04-19	1985-08-13	American Home Products Corporation	2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4657757A (en) †	1985-03-29	1987-04-14	Schering Corporation	Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
US4601894A (en) *	1985-03-29	1986-07-22	Schering Corporation	Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
EP0418596A3 (en) *	1989-09-21	1991-10-23	American Cyanamid Company	Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5451409A (en)	1993-11-22	1995-09-19	Rencher; William F.	Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
GB9401894D0 (en) *	1994-02-01	1994-03-30	Rhone Poulenc Rorer Ltd	New compositions of matter
US6274171B1 (en) *	1996-03-25	2001-08-14	American Home Products Corporation	Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es)	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
CA2216215A1 (en) *	1997-04-05	1998-10-05	Isa Odidi	Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
US6210710B1 (en)	1997-04-28	2001-04-03	Hercules Incorporated	Sustained release polymer blend for pharmaceutical applications
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU1789301A (en) *	1999-11-22	2001-06-04	Alza Corporation	Osmotic dosage form comprising first and second
US6350471B1 (en) †	2000-05-31	2002-02-26	Pharma Pass Llc	Tablet comprising a delayed release coating
US6703044B1 (en) *	2002-10-25	2004-03-09	Dexcel Pharma Tech, Ltd	Venlafaxine formulations
EP1473030B2 (de)	2003-05-02	2014-05-14	Dexcel Ltd.	Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin
EP1523981A1 (de) †	2003-10-13	2005-04-20	Wyeth	Venlafaxine-Zubereitungen mit verlängerter Freisetzung

2003
- 2003-05-02 EP EP03101216.4A patent/EP1473030B2/de not_active Expired - Lifetime
- 2003-05-02 ES ES03101216T patent/ES2277030T3/es not_active Expired - Lifetime
- 2003-05-02 PT PT03101216T patent/PT1473030E/pt unknown
- 2003-05-02 AT AT03101216T patent/ATE344659T1/de active
- 2003-05-02 DE DE60309565.8T patent/DE60309565T3/de not_active Expired - Lifetime
- 2003-12-11 CA CA002524241A patent/CA2524241A1/en not_active Abandoned
- 2003-12-11 US US10/555,310 patent/US8105627B2/en not_active Expired - Fee Related
- 2003-12-11 WO PCT/IL2003/001056 patent/WO2004096186A1/en not_active Ceased

Also Published As

Publication number	Publication date
US8105627B2 (en)	2012-01-31
PT1473030E (pt)	2007-01-31
AU2003285739A1 (en)	2004-11-23
EP1473030B2 (de)	2014-05-14
DE60309565D1 (de)	2006-12-21
EP1473030A1 (de)	2004-11-03
CA2524241A1 (en)	2004-11-11
EP1473030B1 (de)	2006-11-08
DE60309565T3 (de)	2015-01-15
US20070082049A1 (en)	2007-04-12
ES2277030T3 (es)	2007-07-01
DE60309565T2 (de)	2007-03-15
HK1070821A1 (en)	2005-06-30
WO2004096186A1 (en)	2004-11-11

Similar Documents

Publication	Publication Date	Title
AU686168B2 (en)	1998-02-05	Controlled release formulations coated with aqueous dispersions of acrylic polymers
ATE344659T1 (de)	2006-11-15	Tablettenzubereitung mit verlängerter freisetzung von venlafaxin
US7070806B2 (en)	2006-07-04	Controlled release formulations coated with aqueous dispersions of acrylic polymers
JO2555B1 (en)	2010-09-05	Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent
WO2007103557A3 (en)	2008-11-20	Coating capsules with active pharmaceutical ingredients
US5859060A (en)	1999-01-12	Timed release tablet comprising naproxen and pseudoepherine
ATE544447T1 (de)	2012-02-15	Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
BR0103033A (pt)	2002-03-05	Partìculas farmacêuticas de sabor mascarado
MX2007000008A (es)	2007-03-07	Formas farmaceuticas orales, protegidas frente al abuso, que contienen (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil) fenol.
ATE376414T1 (de)	2007-11-15	Pellet formulierung mit gesteuerter freisetzung
YU31599A (sh)	2000-03-21	Brzo oslobadjajući i za ukus maskirajući farmaceutski oblik doze
CA2306103A1 (en)	1999-04-22	Novel once-a-day controlled release sulfonylurea formulation
DE69528838T2 (de)	2003-07-10	Verbesserte,ibuprofen und codein enthaltende,pharmazeutische zusammensetzungen
JP5627854B2 (ja)	2014-11-19	胃の逆流抵抗性投薬形態
IL161628A0 (en)	2004-09-27	Pharmaceutical dosage form with multiple coatings
BR0211198A (pt)	2004-08-10	Composições farmacêuticas e seu uso
BR0014965A (pt)	2002-10-01	Composição de revestimento de pronta liberação, endurecìvel e comestìvel, forma de dosagem sólida, e, método para formar uma composição de revestimento de pronta liberação, endurecìvel e comestìvel
CA2555295A1 (en)	2005-08-18	Extended release coated mini-tablets of venlafaxine hydrochloride
EP3329910B1 (de)	2022-12-14	Pharmazeutische zusammensetzung zur vorbeugung oder behandlung von nagelmykose und herstellungsverfahren dafür
MXPA05004412A (es)	2005-11-23	Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas.
Kotagale et al.	2010	Carbopol 934-sodium alginate-gelatin mucoadhesive ondansetron tablets for buccal delivery: Effect of PH modifiers
JP2005538117A5 (de)	2006-09-07
CN101822649B (zh)	2011-12-07	一种带花彩的片剂的制备方法
BR0115206A (pt)	2003-10-07	Composições hidroliticamente instáveis
RU2008137778A (ru)	2010-03-27	Лекарственная форма с модифицированным высвобождением 6-метил-2-этил-3-гидроксипиридина сукцината

Legal Events

Date

Code

Title

Description

2007-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1473030

Country of ref document: EP